The INI has a new website!

This is a legacy webpage. Please visit the new site to ensure you are seeing up to date information.

Skip to content

DOE

Seminar

A3 Clinical Trials

Krams, M (Wyeth Pharmaceuticals)
Thursday 24 July 2008, 14:30-15:00

Seminar Room 2, Newton Institute Gatehouse

Abstract

Stephen Senn will discuss lost opportunities for the application of design theory in drug development giving examples where theoreticians have not aid sufficient attention to design realities but also cases where practitioners have missed applying useful theory. Michael Krams will cover the 'hot topic' of adaptive design using various case studies, illustrating these from many perspectives, including those of investigators, researchers, patients and data monitoring committees. The objective of this session will be to illustrate areas in which design theory can make a real contribution to drug development provided that genuine collaboration with practitioners is sought.

Presentation

[pdf ]

Back to top ∧